In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 31 for your search:
Drug:  alemtuzumab
Find trials that include:  Any drugs shown
Trial Status:  Active
Start Over
        Show
1.

Phase: Phase III
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2006-006130-17, NCT00646854

2.

Phase: Phase III
Type: Treatment
Status: Active
Age: 61 to 80
Sponsor: Other
Protocol IDs: DSHNHL 2006-1B / ACT-2, BMBF GFVT 01014715, NCT00725231

3.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 70 and under
Sponsor: Other
Protocol IDs: 8713-HIMSUM, NCT00058825

4.

Phase: Phase II, Phase I
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 69
Sponsor: NCI
Protocol IDs: 070195, 07-C-0195, NCI-07-C-0195, NCT00520130

5.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 21 and under
Sponsor: Other
Protocol IDs: CCI #07-00119, CHLA-#07-00119, NCT00730314

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: RHM CAN0638, 2008-007043-14, NCT01422603

7.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2012-0501, NCI-2013-01666, NCT01875237

8.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: Under 22
Sponsor: Other
Protocol IDs: AAAK8060, NCT02061800

9.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 10 to 80
Sponsor: NCI, NHLBI
Protocol IDs: 140077, 14-H-0077, NCT02105766

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: MF/SS, NCT00157274

11.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 85
Sponsor: NHLBI
Protocol IDs: 060190, 06-H-0190, NHLBI-06-H-0190, NCT00345345

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 25 and under
Sponsor: Other
Protocol IDs: H-8701-MOHEL, MOHEL, NCT00368355

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 55 and under
Sponsor: NCI, Other
Protocol IDs: 2007.00, NCI-2009-01550, P30CA015704, FHCRC-2007.00, 6301, NCT00553098

14.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: BIO 07-122, NCT00618969

15.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: 09-0679-04, NCT00997386

16.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 65 and over
Sponsor: NCI, Other
Protocol IDs: CDR0000659098, ECOG-E1908, E1908, NCT01013961

17.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: NCI
Protocol IDs: 100011, 10-C-0011, NCT01030900

18.

Phase: Phase II
Type: Treatment
Status: Active
Age: 0 to 26
Sponsor: Other
Protocol IDs: L 10,321, NYMC 525, NCT01049854

19.

Phase: Phase II
Type: Supportive care
Status: Active
Age: 16 to 70
Sponsor: Other
Protocol IDs: UHN REB 07-0436C, NCT00775632

20.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 69
Sponsor: Other
Protocol IDs: UCL/10/0241, LRF-09041, EU-21081, CRUK-UCL-PROT4, ProT4 (UCL/10/0241), PROT4, CRUK-UCL-10/0241, NCT01240525

21.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 10H06, NCI-2011-00514, STU00044115, NCT01361711

22.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 11-304, NCCN Protocol Number: NCCN-001, GSK Protocol Number: OFT115580, NCT01465334

23.

Phase: Phase II
Type: Treatment
Status: Active
Age: 2 months to 30 years
Sponsor: Other
Protocol IDs: RIC for UBCT in NMD, PRO13100018, NCT01962415

24.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 75
Sponsor: Pharmaceutical / Industry
Protocol IDs: CMAB004, NCT01982175

25.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 4 months to 45 years
Sponsor: NCI, Other
Protocol IDs: BMTCTN1204, 2U10HL069294-11, NCT01998633
1   
New Search